What is Core Quantum Technologies?
Core Quantum Technologies is dedicated to enhancing the precision and duration of nanoscale biological imaging. The company's proprietary micelle-encapsulated nanocrystals offer an unblinking and long-lasting insight into nanoscale activity, a significant improvement over traditional quantum dots that suffer from blinking and signal degradation. Founded by researchers from Ohio State University, including Drs. Gang Ruan and Jessica Winter, the company commercializes MultiDots and MagDots technology. This innovation promises to improve the quality of biological data, thereby supporting advancements in human life sciences. The company's technological foundation is built upon key publications detailing the potential of magnetic manipulation and fluorescent tracking of hybrid nanostructures, as well as advancements in alternating-color quantum dot nanocomposites for particle tracking.
How much funding has Core Quantum Technologies raised?
Core Quantum Technologies has raised a total of $69K across 1 funding round:
Debt
$69K
Debt (2021): $69K with participation from PPP
Key Investors in Core Quantum Technologies
PPP
Public-Private Partnership
What's next for Core Quantum Technologies?
With this recent influx of substantial expansion capital, Core Quantum Technologies is poised for significant growth and scaling of its operations. The company's strategic focus will likely involve expanding its research and development capabilities, enhancing manufacturing processes for its advanced imaging probes, and broadening its market reach within the biotechnology and pharmaceutical sectors. Further investment at this significant Series B/C stage indicates strong investor confidence in the company's technology and its potential to disrupt the field of nanoscale biological imaging, paving the way for more detailed and reliable scientific discovery.
See full Core Quantum Technologies company page
